転移性骨腫瘍治療のグローバル市場調査 2019年

• 英文タイトル：Global Metastatic Bone Tumor Treatment Market Professional Survey Report 2019

• レポートコード：QYR9NV08280
• 出版社/出版日：QYResearch / 2019年11月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、転移性骨腫瘍治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療に、用途別には、病院、がんリハビリテーションセンター、専門クリニック、外来手術センターにセグメント区分し、転移性骨腫瘍治療の世界市場を分析しました。

・エグゼクティブ・サマリー
・転移性骨腫瘍治療の世界市場概要
・転移性骨腫瘍治療の製造コスト構成分析
・転移性骨腫瘍治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・転移性骨腫瘍治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・転移性骨腫瘍治療のセグメント分析（種類別）
（外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療）
・転移性骨腫瘍治療のセグメント分析（用途別）
（病院、がんリハビリテーションセンター、専門クリニック、外来手術センター）
・転移性骨腫瘍治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novartis AG、Amgen Inc、Catena Pharmaceuticals、Hoffmann-La Roche Ltd、Eli Lilly、Pfizer、）
・転移性骨腫瘍治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Metastatic Bone Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Metastatic Bone Tumor Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metastatic Bone Tumor Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Metastatic Bone Tumor Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Metastatic Bone Tumor Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis AG
Amgen Inc
Catena Pharmaceuticals
Hoffmann-La Roche Ltd
Eli Lilly
Pfizer
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
External Radiation Therapy
Chemotherapy
Hormone Therapy
Immunotherapy
Medications
Surgical treatment

Segment by Application
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Metastatic Bone Tumor Treatment
1.1 Definition of Metastatic Bone Tumor Treatment
1.2 Metastatic Bone Tumor Treatment Segment by Type
1.2.1 Global Metastatic Bone Tumor Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 External Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Hormone Therapy
1.2.5 Immunotherapy
1.2.6 Medications
1.2.7 Surgical treatment
1.3 Metastatic Bone Tumor Treatment Segment by Applications
1.3.1 Global Metastatic Bone Tumor Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Cancer Rehabilitation Centers
1.3.4 Specialty Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Global Metastatic Bone Tumor Treatment Overall Market
1.4.1 Global Metastatic Bone Tumor Treatment Revenue (2014-2025)
1.4.2 Global Metastatic Bone Tumor Treatment Production (2014-2025)
1.4.3 North America Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.4 Europe Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.5 China Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.6 Japan Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.8 India Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Metastatic Bone Tumor Treatment
2.3 Manufacturing Process Analysis of Metastatic Bone Tumor Treatment
2.4 Industry Chain Structure of Metastatic Bone Tumor Treatment

3 Development and Manufacturing Plants Analysis of Metastatic Bone Tumor Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Metastatic Bone Tumor Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Metastatic Bone Tumor Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Metastatic Bone Tumor Treatment Production and Capacity Analysis
4.2 Metastatic Bone Tumor Treatment Revenue Analysis
4.3 Metastatic Bone Tumor Treatment Price Analysis
4.4 Market Concentration Degree

5 Metastatic Bone Tumor Treatment Regional Market Analysis
5.1 Metastatic Bone Tumor Treatment Production by Regions
5.1.1 Global Metastatic Bone Tumor Treatment Production by Regions
5.1.2 Global Metastatic Bone Tumor Treatment Revenue by Regions
5.2 Metastatic Bone Tumor Treatment Consumption by Regions
5.3 North America Metastatic Bone Tumor Treatment Market Analysis
5.3.1 North America Metastatic Bone Tumor Treatment Production
5.3.2 North America Metastatic Bone Tumor Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Metastatic Bone Tumor Treatment Import and Export
5.4 Europe Metastatic Bone Tumor Treatment Market Analysis
5.4.1 Europe Metastatic Bone Tumor Treatment Production
5.4.2 Europe Metastatic Bone Tumor Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Metastatic Bone Tumor Treatment Import and Export
5.5 China Metastatic Bone Tumor Treatment Market Analysis
5.5.1 China Metastatic Bone Tumor Treatment Production
5.5.2 China Metastatic Bone Tumor Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Metastatic Bone Tumor Treatment Import and Export
5.6 Japan Metastatic Bone Tumor Treatment Market Analysis
5.6.1 Japan Metastatic Bone Tumor Treatment Production
5.6.2 Japan Metastatic Bone Tumor Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Metastatic Bone Tumor Treatment Import and Export
5.7 Southeast Asia Metastatic Bone Tumor Treatment Market Analysis
5.7.1 Southeast Asia Metastatic Bone Tumor Treatment Production
5.7.2 Southeast Asia Metastatic Bone Tumor Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Metastatic Bone Tumor Treatment Import and Export
5.8 India Metastatic Bone Tumor Treatment Market Analysis
5.8.1 India Metastatic Bone Tumor Treatment Production
5.8.2 India Metastatic Bone Tumor Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Metastatic Bone Tumor Treatment Import and Export

6 Metastatic Bone Tumor Treatment Segment Market Analysis (by Type)
6.1 Global Metastatic Bone Tumor Treatment Production by Type
6.2 Global Metastatic Bone Tumor Treatment Revenue by Type
6.3 Metastatic Bone Tumor Treatment Price by Type

7 Metastatic Bone Tumor Treatment Segment Market Analysis (by Application)
7.1 Global Metastatic Bone Tumor Treatment Consumption by Application
7.2 Global Metastatic Bone Tumor Treatment Consumption Market Share by Application (2014-2019)

8 Metastatic Bone Tumor Treatment Major Manufacturers Analysis
8.1 Novartis AG
8.1.1 Novartis AG Metastatic Bone Tumor Treatment Production Sites and Area Served
8.1.2 Novartis AG Product Introduction, Application and Specification
8.1.3 Novartis AG Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen Inc
8.2.1 Amgen Inc Metastatic Bone Tumor Treatment Production Sites and Area Served
8.2.2 Amgen Inc Product Introduction, Application and Specification
8.2.3 Amgen Inc Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Catena Pharmaceuticals
8.3.1 Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Sites and Area Served
8.3.2 Catena Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hoffmann-La Roche Ltd
8.4.1 Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Sites and Area Served
8.4.2 Hoffmann-La Roche Ltd Product Introduction, Application and Specification
8.4.3 Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eli Lilly
8.5.1 Eli Lilly Metastatic Bone Tumor Treatment Production Sites and Area Served
8.5.2 Eli Lilly Product Introduction, Application and Specification
8.5.3 Eli Lilly Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer
8.6.1 Pfizer Metastatic Bone Tumor Treatment Production Sites and Area Served
8.6.2 Pfizer Product Introduction, Application and Specification
8.6.3 Pfizer Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Metastatic Bone Tumor Treatment Market
9.1 Global Metastatic Bone Tumor Treatment Market Trend Analysis
9.1.1 Global Metastatic Bone Tumor Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Metastatic Bone Tumor Treatment Regional Market Trend
9.2.1 North America Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.2 Europe Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.3 China Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.4 Japan Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.5 Southeast Asia Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.6 India Metastatic Bone Tumor Treatment Forecast 2019-2025
9.3 Metastatic Bone Tumor Treatment Market Trend (Product Type)
9.4 Metastatic Bone Tumor Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Metastatic Bone Tumor Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Metastatic Bone Tumor Treatment
Table Global Metastatic Bone Tumor Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Production Market Share by Types in 2018
Figure External Radiation Therapy Product Picture
Figure Chemotherapy Product Picture
Figure Hormone Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Medications Product Picture
Figure Surgical treatment Product Picture
Table Global Metastatic Bone Tumor Treatment Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Cancer Rehabilitation Centers
Figure Specialty Clinics
Figure Ambulatory Surgical Centers
Figure Global Metastatic Bone Tumor Treatment Revenue (Million USD) (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Production (K Units) (2014-2025)
Figure North America Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Europe Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure China Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Japan Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure India Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Table Metastatic Bone Tumor Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Metastatic Bone Tumor Treatment in 2018
Figure Manufacturing Process Analysis of Metastatic Bone Tumor Treatment
Figure Industry Chain Structure of Metastatic Bone Tumor Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Metastatic Bone Tumor Treatment Manufacturing Plants Distribution
Table Metastatic Bone Tumor Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Metastatic Bone Tumor Treatment Capacity (K Units) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Production (K Units) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Metastatic Bone Tumor Treatment Production Share by Manufacturers in 2018
Table Metastatic Bone Tumor Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Metastatic Bone Tumor Treatment Revenue Share by Manufacturers in 2018
Table Metastatic Bone Tumor Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Metastatic Bone Tumor Treatment Production by Regions 2014-2019 (K Units)
Table Global Metastatic Bone Tumor Treatment Production Market Share by Regions 2014-2019
Figure Global Metastatic Bone Tumor Treatment Production Market Share by Regions in 2018
Table Global Metastatic Bone Tumor Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Metastatic Bone Tumor Treatment Revenue Market Share by Regions 2014-2019
Figure Global Metastatic Bone Tumor Treatment Revenue Market Share by Regions in 2018
Table Global Metastatic Bone Tumor Treatment Consumption by Regions 2014-2019 (K Units)
Table Global Metastatic Bone Tumor Treatment Consumption Market Share by Regions 2014-2019
Figure North America Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure North America Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Europe Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Europe Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure China Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure China Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Japan Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Japan Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure India Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure India Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Global Consumption Metastatic Bone Tumor Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Metastatic Bone Tumor Treatment Market Share by Application (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Novartis AG Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Novartis AG Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Novartis AG Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Amgen Inc Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Amgen Inc Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Amgen Inc Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Amgen Inc Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Catena Pharmaceuticals Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Eli Lilly Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Eli Lilly Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Eli Lilly Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Eli Lilly Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Pfizer Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Pfizer Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Pfizer Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Pfizer Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Main Business and Markets Served
Figure Global Metastatic Bone Tumor Treatment Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Metastatic Bone Tumor Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Metastatic Bone Tumor Treatment Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Metastatic Bone Tumor Treatment by Type (2019-2025)
Table Global Consumption (K Units) of Metastatic Bone Tumor Treatment by Application (2019-2025)
Table Metastatic Bone Tumor Treatment Distributors List
Table Metastatic Bone Tumor Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

神経内分泌腫瘍治療のグローバル市場：規模・現状・予測2019-2025

Global Neuroendocrine Tumor Treatment Market Size, Status and Forecast 2019-2025
QYR9NV18206 2019年11月18日 99Pages
※当調査レポートでは、神経内分泌腫瘍治療の世界市場について調査・分析し、神経内分泌腫瘍治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクト...

神経内分泌腫瘍治療のグローバル市場：規模・現状・予測2019-2025

線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025

Global Desmoplastic Small Round Cell Tumor Treatment Market Size, Status and Forecast 2019-2025
QYR9NV17841 2019年11月18日 90Pages
※当調査レポートでは、線維形成性小円形細胞腫瘍の治療の世界市場について調査・分析し、線維形成性小円形細胞腫瘍の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫療法、外科手術、化学療法、放射線...

線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025

骨髄移植拒絶反応の治療のグローバル市場調査 2019年

Global Bone Marrow Transplant Rejection Treatment Market Professional Survey Report 2019
QYR9NV01869 2019年11月12日 114Pages
※本調査レポートは、骨髄移植拒絶反応の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザチオプリン、副腎皮質刺激ホルモン、シクロホスファミド、シクロスポ...

転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025

Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2019-2025
QYR9NV18156 2019年11月18日 93Pages
※当調査レポートでは、転移性悪性黒色腫療法の世界市場について調査・分析し、転移性悪性黒色腫療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫療法、標的療法、その他）、用途別（病院、医学研究機関...

転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025

骨形成タンパク質7のグローバル市場調査 2019年

Global Bone Morphogenetic Proteins 7 Market Professional Survey Report 2019
QYR9NV01870 2019年11月12日 103Pages
※本調査レポートは、骨形成タンパク質7の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、スポンジ、ゲルに、用途別には、脊椎固定術、外傷手術、口腔顎顔面外科手術、...

腫瘍特異抗原のグローバル市場：規模・現状・予測2019-2025

Global Tumor-Specific Antigen Market Size, Status and Forecast 2019-2025
QYR9NV18512 2019年11月18日 91Pages
※当調査レポートでは、腫瘍特異抗原の世界市場について調査・分析し、腫瘍特異抗原の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コーディング領域、非コーディング領域）、用途別（創薬、開発、診断、臨床＆...

線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025 Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach …
線維形成性小円形細胞腫瘍の治療のグローバル市場：規模・現状・予測2019-2025 Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach …
神経内分泌腫瘍治療のグローバル市場：規模・現状・予測2019-2025 Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …
神経内分泌腫瘍治療のグローバル市場：規模・現状・予測2019-2025 Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …
転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …